These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33517680)

  • 21. Pregnancy outcomes after laparoscopic ovarian drilling in women with polycystic ovarian syndrome.
    Al-Ojaimi EH
    Saudi Med J; 2006 Apr; 27(4):519-25. PubMed ID: 16598331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between 24-hour ambulatory blood pressure measurement and selected biochemical and anthropometric parameters in women with polycystic ovary syndrome.
    Franik G; Bizoń A; Szynkaruk-Matusiak M; Osowska K; Dryś A; Olszanecka-Glinianowicz M; Madej P
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3947-3954. PubMed ID: 34156673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychological Distress Is More Prevalent in Fertile Age and Premenopausal Women With PCOS Symptoms: 15-Year Follow-Up.
    Karjula S; Morin-Papunen L; Auvinen J; Ruokonen A; Puukka K; Franks S; Järvelin MR; Tapanainen JS; Jokelainen J; Miettunen J; Piltonen TT
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1861-1869. PubMed ID: 28323926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early initiation of anti-androgen treatment is associated with increased probability of spontaneous conception leading to childbirth in women with polycystic ovary syndrome: a population-based multiregistry cohort study in Sweden.
    Elenis E; Desroziers E; Persson S; Sundström Poromaa I; Campbell RE
    Hum Reprod; 2021 Apr; 36(5):1427-1435. PubMed ID: 33454768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep disorders in polycystic ovary syndrome: influence of obesity and hyperandrogenism.
    Hachul H; Polesel DN; Tock L; Carneiro G; Pereira AZ; Zanella MT; Tufik S; Togeiro SM
    Rev Assoc Med Bras (1992); 2019 Mar; 65(3):375-383. PubMed ID: 30994836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
    Koivunen R; Pouta A; Franks S; Martikainen H; Sovio U; Hartikainen AL; McCarthy MI; Ruokonen A; Bloigu A; Järvelin MR; Morin-Papunen L;
    Hum Reprod; 2008 Sep; 23(9):2134-9. PubMed ID: 18544581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
    Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
    Zhang HY; Guo CX; Zhu FF; Qu PP; Lin WJ; Xiong J
    Arch Gynecol Obstet; 2013 Mar; 287(3):525-31. PubMed ID: 23108387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.
    Legro RS; Bentley-Lewis R; Driscoll D; Wang SC; Dunaif A
    J Clin Endocrinol Metab; 2002 May; 87(5):2128-33. PubMed ID: 11994352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
    Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
    Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
    Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with self-report of polycystic ovary syndrome in the Coronary Artery Risk Development in Young Adults study (CARDIA).
    Kim C; Schreiner PJ; Siscovick D; Wang A; Wellons MF; Ebong I; Vu TH; Appiah D; Catov J; Schisterman EF; Yin Z; Lewis CE
    BMC Womens Health; 2023 May; 23(1):248. PubMed ID: 37161406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the PCOS phenotype with age.
    Hsu MI
    Steroids; 2013 Aug; 78(8):761-6. PubMed ID: 23624031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age at adiposity rebound in childhood is associated with PCOS diagnosis and obesity in adulthood-longitudinal analysis of BMI data from birth to age 46 in cases of PCOS.
    Koivuaho E; Laru J; Ojaniemi M; Puukka K; Kettunen J; Tapanainen JS; Franks S; Järvelin MR; Morin-Papunen L; Sebert S; Piltonen TT
    Int J Obes (Lond); 2019 Jul; 43(7):1370-1379. PubMed ID: 30718819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
    Ezeh U; Ezeh C; Pisarska MD; Azziz R
    Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity.
    Couto Alves A; Valcarcel B; Mäkinen VP; Morin-Papunen L; Sebert S; Kangas AJ; Soininen P; Das S; De Iorio M; Coin L; Ala-Korpela M; Järvelin MR; Franks S
    Int J Obes (Lond); 2017 Sep; 41(9):1331-1340. PubMed ID: 28546543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
    Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI
    Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.